Tags » cannabidiol

Posts
Seth A. Goldberg wrote: FDA's CBD Enforcement Continues
[caption id="attachment_37" align="alignnone" width="125"] Seth A. Goldberg[/caption] On April 20, the FDA issued warning letters to two CBD companies - BIOTA Biosciences and Homero Corp., dba Natures CBD Oil Distribution - directing them to remov (More)
[caption id="attachment_37" align="alignleft" width="125"] Seth A. Goldberg[/caption] The long awaited regulations establishing a regulatory framework under the 2018 Farm Bill passed last December were issued today (10/29/19).  An Interim Final R (More)
Despite recent bipartisan calls on the FDA to regulate hemp-derived CBD products, the U.S. Food & Drug Administration appears to be adhering to the status quo, at least with respect to issuing warning letters to companies deemed noncompliant wi (More)
Despite recent bipartisan calls on the FDA to regulate hemp-derived CBD products, the U.S. Food & Drug Administration appears to be adhering to the status quo, at least with respect to issuing warning letters to companies deemed noncompliant with (More)
The past week has shown the challenges that the cannabis industry supply chain—manufacturers, processors, distributors and dispensaries—faces, as regulators target claims relating to the health benefits of CBD and media outlets report, without an (More)
According to a research report published by Cowen & Co. earlier this year, the investment bank believes that the U.S. market for cannabidiol (CBD) consumer goods could reach $16 billion—a “conservative” forecast—by 2025, up from between (More)
At the U.S. Food and Drug Administration’s (FDA) public hearing on May 31, 2019 (read more about the hearing), over 100 people presented to a panel of FDA stakeholders and to over 500 attendees. Last week, FDA stated in a post that it recognizes (More)